History
  • No items yet
midpage
Compassion Over Killing v. U.S. Food & Drug Administration
2017 U.S. App. LEXIS 3484
| 9th Cir. | 2017
Read the full case

Background

  • Compassion Over Killing, Animal Legal Defense Fund, and six consumers petitioned FDA, FTC, AMS, and FSIS to require egg cartons to disclose hen housing ("Free-Range," "Cage-Free," or "Eggs from Caged Hens").
  • Petitioners argued consumers are misled by imagery/phrases (e.g., "all natural") and that eggs from caged hens are nutritionally inferior and have higher Salmonella risk.
  • Each agency denied the petition: FSIS and AMS said they lacked statutory authority; FTC found insufficient evidence that deceptive practices were "prevalent" and preferred case-by-case enforcement; FDA found no showing that housing is a materially omitted fact and prioritized other rulemakings.
  • Petitioners sued under the APA alleging agencies acted arbitrarily and capriciously; district court granted summary judgment to defendants.
  • Ninth Circuit reviewed de novo, applying highly deferential review to agencies' refusals to institute rulemaking, and affirmed summary judgment for all agencies.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
FSIS authority to regulate shell-egg labeling EPIA authorizes FSIS to require housing disclosures on egg cartons EPIA limits FSIS authority to "egg products," not shell eggs FSIS lacks authority; denial upheld
AMS authority to promulgate mandatory shell-egg labeling AMA authorizes AMS to set standards that include mandatory labels AMA authorizes voluntary standards and recommendations, not mandatory nationwide labels AMS lacks authority for mandatory requirements; denial upheld
FTC rulemaking for deceptive labeling Egg labels and imagery are deceptive and widespread; rulemaking required FTCA allows rulemaking only for "prevalent" practices; petition lacked widespread evidence; agency may enforce individually FTC reasonably found lack of prevalence and rationally preferred individual enforcement; denial upheld
FDA rulemaking for misbranding or omissions Labels affirmatively misrepresent housing and omissions are material because of health/nutrition risks FDA found petition’s scientific evidence unreliable and held housing not established as a material omitted fact; enforcement and priorities justify denial FDA’s factual and resource-allocation judgments were reasonable and denial met minimal APA explanation requirement; denial upheld

Key Cases Cited

  • Massachusetts v. EPA, 549 U.S. 497 (agency refusal to act reviewed with deference; must give reasonable explanation)
  • SEC v. Chenery Corp., 332 U.S. 194 (agency may choose rulemaking or ad hoc enforcement)
  • Balt. Gas & Elec. Co. v. Nat. Res. Def. Council, 462 U.S. 87 (courts should be most deferential on agency scientific judgments)
  • N. Plains Res. Council v. Surface Transp. Bd., 668 F.3d 1067 (deference to agency technical/scientific determinations)
  • In re Barr Labs., 930 F.2d 72 (courts should not second-guess agency priority-setting)
  • WWHT, Inc. v. F.C.C., 656 F.2d 807 (agency denials of rulemaking are reviewable under APA)
Read the full case

Case Details

Case Name: Compassion Over Killing v. U.S. Food & Drug Administration
Court Name: Court of Appeals for the Ninth Circuit
Date Published: Feb 27, 2017
Citation: 2017 U.S. App. LEXIS 3484
Docket Number: 15-15107
Court Abbreviation: 9th Cir.